These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28143865)

  • 21. Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry.
    Colombo MG; Kirchberger I; Amann U; Heier M; Thilo C; Kuch B; Peters A; Meisinger C
    BMC Cardiovasc Disord; 2017 Jul; 17(1):198. PubMed ID: 28738785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum potassium and cardiovascular mortality.
    Fang J; Madhavan S; Cohen H; Alderman MH
    J Gen Intern Med; 2000 Dec; 15(12):885-90. PubMed ID: 11119186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
    Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
    JAMA Netw Open; 2018 Nov; 1(7):e183874. PubMed ID: 30646338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
    Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis.
    Kendrick JB; Zelnick L; Chonchol MB; Siscovick D; Hoofnagle AN; Ix JH; Sarnak M; Shlipak MG; Kestenbaum B; de Boer IH
    Am J Nephrol; 2017; 45(2):118-126. PubMed ID: 27941322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.
    Lim CC; Teo BW; Ong PG; Cheung CY; Lim SC; Chow KY; Meng CC; Lee J; Tai ES; Wong TY; Sabanayagam C
    Eur J Prev Cardiol; 2015 Aug; 22(8):1018-26. PubMed ID: 24857889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 24-hour urine phosphorus excretion and mortality and cardiovascular events.
    Palomino HL; Rifkin DE; Anderson C; Criqui MH; Whooley MA; Ix JH
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1202-10. PubMed ID: 23539231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
    Weinberg JM; Appel LJ; Bakris G; Gassman JJ; Greene T; Kendrick CA; Wang X; Lash J; Lewis JA; Pogue V; Thornley-Brown D; Phillips RA;
    Arch Intern Med; 2009 Sep; 169(17):1587-94. PubMed ID: 19786678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis.
    Ohnishi T; Kimachi M; Fukuma S; Akizawa T; Fukuhara S
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):873-881. PubMed ID: 31048327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J
    Circulation; 2018 Mar; 137(13):1320-1330. PubMed ID: 29025765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Potassium Levels and Short-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction.
    Ma W; Liang Y; Zhu J; Yang Y; Tan H; Yu L; Gao X; Feng G; Li J
    Angiology; 2016 Sep; 67(8):729-36. PubMed ID: 26626107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients.
    Nishihara T; Tokitsu T; Sueta D; Takae M; Oike F; Fujisue K; Usuku H; Takashio S; Hanatani S; Kanazawa H; Arima Y; Sakamoto K; Izumiya Y; Yamabe H; Kaikita K; Yamamoto E; Tsujita K
    Am J Hypertens; 2018 Sep; 31(10):1098-1105. PubMed ID: 29985986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Epidemiology of Hyperkalemia: Cardiac and Kidney Long-term Health Outcomes.
    Mclean A; Nath M; Sawhney S
    Am J Kidney Dis; 2022 Apr; 79(4):527-538.e1. PubMed ID: 34419518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
    Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R;
    Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High and low serum potassium associated with cardiovascular events in diuretic-treated patients.
    Cohen HW; Madhavan S; Alderman MH
    J Hypertens; 2001 Jul; 19(7):1315-23. PubMed ID: 11446723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.
    Wang HH; Hung CC; Hwang DY; Kuo MC; Chiu YW; Chang JM; Tsai JC; Hwang SJ; Seifter JL; Chen HC
    PLoS One; 2013; 8(7):e67140. PubMed ID: 23843989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and outcomes of hyperkalemia in hospitalized patients: potential implications for care.
    Wetmore JB; Yan H; Peng Y; Gilbertson DT; Herzog CA
    Am Heart J; 2021 Nov; 241():59-67. PubMed ID: 34293294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
    Weir MR; Mayo MR; Garza D; Arthur SA; Berman L; Bushinsky D; Wilson DJ; Epstein M
    J Hypertens; 2017 May; 35 Suppl 1(Suppl 1):S57-S63. PubMed ID: 28129247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.